Arden Barry (@ArdenBarry) header
Arden Barry (@ArdenBarry) profile picture

Pharmacist Clinician-Researcher in Cardiology | Associate Professor (Partner) @ubcpharmacy | Editorial Board @CPJ_RPC @CJCJournals | #cardiotwitter #TwitteRx

Vancouver, British Columbia
Joined June 2012
Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)Photo by Arden Barry (@ArdenBarry)
A testimonial from our 🇨🇦 colleague and Chair of the PRN Communications and Social Media Committee Dr. Arden Barry from @UBC: Why do you contribute to the Cardiology PRN?
1
4
553
Congratulations, @ZackDumontYQR! This paper, as stated in the title, demonstrates the value we bring to the team and our patients every day.
Congratulations to ACCP member Zack Dumont and co-authors on the recent publication of their article in JACCP! Access the abstract and/or article here: ow.ly/bfA350ZebXC #MakingAnImpact #ACCP #FreetoRead @JACCPJournal
1
164
Welcome back to #TBT! We revisit the PATHWAY-2 trial. The results of this trial informed the class 1, B-R recommendation to use an MRA in resistant HTN in the 2025 AHA/ACC HTN guideline. TY to Harveen Sohi, PGY1 resident in Vancouver 🇨🇦, for contributing this infographic.
1
4
754
The Cardiology & Perioperative PRNs invite members to attend the upcoming "How We Do It webinar, "Balfaxar vs. KCentra: Real-World Implementation and Clinical Experience," on Tuesday, August 25th from 3–4 PM EST. Please see the PRN Community page for the Zoom Link!
4
10
692
The FDA has approved the first oral PCSK9 inhibitor, enlicitide, to lower LDL-C in patients with hypercholesterolemia. fda.gov/drugs/news-events-hu…
3
126
Congratulations, Jim!
Congratulations to Dr. Jim Coons on being selected for this year’s ACCP PRN Seed Grant for his project titled “Selexipag treatment persistence and pharmacogenomics.” We look forward to seeing how your research impacts the care of PAH patients!
164
It’s #TBT! Going back to 2004 with the Camelot trial, the first major trial that showed lowering blood pressure slows down atherosclerosis progression. Thank you to PGY1 Resident Maryam Alarfaj for making this infographic! #cardiotwitter
1
1
7
484
The Card PRN has a new website: cardprn.accp.com/ This PRN member-exclusive platform was designed to allow members to connect with colleagues across the various cardiology Rx subspecialties. There are two new subcommunities: antithrombotic management and heart failure.
🤖 Made with AI
2
4
447
Our contemporary practice tool to assist #pharmacists in managing patients with heart failure now published in @CPJ_RPC #heartfailure #cardiotwitter utppublishing.com/doi/10.313…
10
193
Happy #TBT! This week, we revisit CLEAR Outcomes, published in @NEJM almost exactly 3 years ago. This was the first CV outcome trial with bempedoic acid in patients with statin intolerance. Thanks to 🇨🇦 PGY1 #pharmacy resident @Arjun_Kandola for this infographic. #cardiotwitter
1
4
8
928
It's another #TBT! 🙏 to Heidi Gonzalez Ramirez of @umsop for revisiting the AURORA trial in this infographic. 💊 AURORA was the first large-scale international trial to assess the effects of statins on CV outcomes in patients with ESRD on HD. #cardiotwitter
1
3
7
564
Higher medication optimization score was associated with lower all-cause mortality or hospitalization in patients with HFrEF. Algorithm can identify patients who may benefit from medication optimization. #CardioTwitter #heartfailure #pharmacists
This algorithm that generates medication optimization scores effectively identifies opportunities for guideline-directed medication therapy optimization in real-world clinical settings. OPEN ACCESS: buff.ly/2xpMOzE
1
94
I'm grateful for the opportunity to have been a guest editor and work with @Ross_Tsuyuki on this supplement dedicated to automated external defibrillators in #pharmacies in @CPJ_RPC. #AED #cardiacarrest journals.sagepub.com/toc/cph…
2
61
It's #TBT! This week, we're revisiting the innovative LA Barbershop Study, where #pharmacist-led management of #hypertension at Black barbershops resulted in an impressive SBP reduction. Thanks to @BetCloPharmD at @UNCHealthRex for making this infographic. #CommunityHealth
2
5
640
For #TBT, we're going back to 2016 for the HOPE-3 trial. Fixed-dose, moderate-intensity rosuvastatin lowered the risk of MACE in patients at intermediate CV risk. TY to Dr. Emily Mattarollo, who was a @lmpsresidency PGY1 resident in 🇨🇦, for creating this infographic!
4
4
702